EGFR and lung cancer: Recently, a genotype–phenotype mapping study based on patient-derived lung organoids was used to understand the Wnt dependency in lung adenocarcinoma; authors demonstrated that the loss of the alveolar identity gene NKX2-1 increases the Wnt dependency in lung cancer, irrespective of the presence of EGFR mutation.